ASML Holding NV vs UnitedHealth Group Incorporated: Strategic Comparison

This in-depth comparison examines ASML Holding NV and UnitedHealth Group Incorporated across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching ASML Holding NV on its own, evaluating UnitedHealth Group Incorporated, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between ASML Holding NV and UnitedHealth Group Incorporated is widest.

On the headline numbers, ASML Holding NV reports annual revenue of $35.3B against $447.6B for UnitedHealth Group Incorporated, while their respective market capitalizations stand at $268.0B and $397.1B. ASML Holding NV is headquartered in Netherlands and UnitedHealth Group Incorporated operates from United States, and those different home markets shape how each company competes.

ASML Holding NV: ASML makes money by selling lithography systems and providing installed-base service, upgrades, software, and field options. Its EUV monopoly creates unusually high strategic importance within the global chip supply chain.

UnitedHealth Group Incorporated: UnitedHealth is best understood as a healthcare operating system: insurance premiums and claims create scale, Optum manages pharmacy and care services, and data flows help price risk, coordinate care, and manage cost.

ASML Holding NV and UnitedHealth Group Incorporated pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between ASML Holding NV and UnitedHealth Group Incorporated.

ASML Holding NV business model: Building one requires components sourced from more than 5,000 suppliers across 16 countries, assembled through a process so intricate that delivery, installation, and commissioning at a customer's fabrication plant takes months. EUV systems represent the apex of ASML's product portfolio and the locus of its pricing power. Instead, ASML sells performance upgrades — enhanced throughput, improved overlay accuracy, expanded process windows — as separately licensed software and hardware packages that customers purchase over the machine's operational lifetime. ASML's pricing power is extraordinary by any industrial standard, and it derives directly from the company's monopoly position. This allows ASML to maintain gross margins on EUV systems that consistently exceed 50 percent and to set pricing that reflects the extraordinary economic value the equipment creates for customers. The problem is, ASML captures a small but growing fraction of this value through its pricing. China's share of ASML's total revenue, which reached approximately 29 percent in the first half of 2023, has been progressively curtailed since the Dutch government declined to renew ASML's export license for EUV systems in 2019. Each new generation of EUV technology commands higher pricing, drives higher service revenue, and further widens the technological gap between ASML and any theoretical competitor.

UnitedHealth Group Incorporated business model: UnitedHealth makes money from insurance premiums, fee-based employer administration, Medicare Advantage and Medicare Part D, Medicaid managed care, pharmacy benefit management through Optum Rx, care delivery and value-based care through Optum Health, and data, consulting, and technology through Optum Insight.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of ASML Holding NV stack up against those of UnitedHealth Group Incorporated.

ASML Holding NV competitive advantage: This service business is characterized by very high switching costs: a chipmaker cannot simply swap out lithography equipment mid-production without catastrophic disruption. The company's headquarters in Veldhoven, adjacent to the Dutch city of Eindhoven, reflects its roots in the Philips industrial ecosystem that made the southern Netherlands a European technology hub in the twentieth century. The physics challenges, the optical engineering requirements, and the supplier ecosystem limitations that China faces are not primarily financial obstacles; they are time and knowledge obstacles that money alone cannot solve on any commercially relevant timeline. ASML's competitive advantage is perhaps the most formidable in the global technology industry, resting on a combination of accumulated technological know-how, supplier ecosystem lock-in, customer switching costs, and regulatory moats that collectively make replication by any competitor — whether private, state-sponsored, or otherwise — extraordinarily difficult. The technological core of ASML's advantage is its mastery of EUV lithography, a technology that the company spent over 20 years and billions of dollars developing before shipping its first commercial EUV machine in 2017. The Carl Zeiss SMT relationship deserves particular emphasis as a competitive moat. ASML's customer relationships also create powerful demand-side moats. This technical advantage was real but not significant, and ASML spent its first several years fighting for every customer order, often competing on price to compensate for its lack of brand recognition.

UnitedHealth Group Incorporated competitive advantage: UnitedHealth's advantage is vertical integration. It combines the largest U.S. health insurer with Optum's pharmacy, care delivery, data, analytics, and services assets, giving it scale in claims, benefits, networks, prescriptions, and care management.

Future prospects matter as much as current results. The growth strategies below explain how ASML Holding NV and UnitedHealth Group Incorporated each plan to expand from here.

ASML Holding NV growth strategy: ASML's growth strategy centers on EUV capacity, High-NA EUV adoption, installed-base service upgrades, deep supplier coordination, and long-term demand from leading-edge logic and memory customers.

UnitedHealth Group Incorporated growth strategy: UnitedHealth is focused on pricing and benefit design, medical cost management, Medicare Advantage discipline, Medicaid and employer offerings, Optum Rx scale, Optum Health care delivery, technology, data analytics, and value-based care capabilities.

A closer look at the financial trajectory of ASML Holding NV and UnitedHealth Group Incorporated rounds out the comparison.

ASML Holding NV: ASML reported EUR32.7B in FY2025 total net sales, EUR9.6B in net income, a 52.8% gross margin, and EUR38.8B of backlog at year-end. Using CorpDigest's USD convention, those figures are shown as about $35.3B of revenue and $10.4B of net income. The key financial drivers are EUV system demand, DUV resilience, installed-base services, High-NA adoption, and export-control limits.

UnitedHealth Group Incorporated: UnitedHealth Group's 2025 revenues were USD 447.6 billion, up 12%. Premium revenue was USD 352.2 billion, products revenue was USD 53.4 billion, services revenue was USD 38.0 billion, and earnings from operations were USD 19.0 billion. Segment revenue before eliminations was USD 344.9 billion for UnitedHealthcare and USD 270.6 billion for Optum.